ArticleJournal of comparative effectiveness research2025

Healthcare costs and treatment patterns associated with glucagon-like peptide 1 receptor agonist use among patients with metabolic dysfunction-associated steatohepatitis.

Elliot B Tapper et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.